Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
Authors
Keywords
Nanoparticles, Endotoxin, Pre-clinical, Immunotoxicity, Thrombosis, Coagulopathy, Hemolysis, Complement activation, Cytokines, Anaphylaxis, Phagocytosis, Protein binding
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 220, Issue -, Pages 571-583
Publisher
Elsevier BV
Online
2015-09-06
DOI
10.1016/j.jconrel.2015.08.056

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.